TLR4 is a novel determinant of the response to paclitaxel in breast cancer
Breast cancer (BC) is the most common cancer and ranks second as a cause of cancer death in women. Every year about one million women diagnosed with breast cancer some of which becomes metastatic leading to decreased patient survival. Paclitaxel (PXL) is a potent cytotoxic drug widely used as a firs...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
OpenSIUC
2014
|
| Online Access: | https://opensiuc.lib.siu.edu/dissertations/845 https://opensiuc.lib.siu.edu/cgi/viewcontent.cgi?article=1848&context=dissertations |